Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8400)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2015 (publication date) through Jun 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Inokuchi M, Otsuki S, Fujimori Y, Sato Y, Nakagawa M, Kojima K. Clinical significance of MET in gastric cancer. World J Gastrointest Oncol 2015; 7(11): 317-327 [PMID: 26600931 DOI: 10.4251/wjgo.v7.i11.317] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i11/317.htm |
| Number | Citing Articles |
| 1 |
Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M. Blum, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ho Yeong Lim, Samuel J. Klempner, Jeeyun Lee. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer. Science Advances 2023; 9(47) doi: 10.1126/sciadv.adk1098
|
| 2 |
Zhen Xu, Pingping Hu, Dong Fang, Lingna Ni, Jianzhong Xu. Electrostatic explanation of D1228V/H/N-induced c-Met resistance and sensitivity to type I and type II kinase inhibitors in targeted gastric cancer therapy. Journal of Molecular Modeling 2019; 25(1) doi: 10.1007/s00894-018-3893-3
|
| 3 |
Fatemeh Moosavi, Ahmad Ebadi, Maryam Mohabbati, Tahereh Damghani, Motahareh Mortazavi, Ramin Miri, Omidreza Firuzi. Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives. European Journal of Pharmacology 2021; 894: 173850 doi: 10.1016/j.ejphar.2021.173850
|
| 4 |
Katia De Marco, Martina Lepore Signorile, Elisabetta Di Nicola, Paola Sanese, Candida Fasano, Giovanna Forte, Vittoria Disciglio, Antonino Pantaleo, Greta Varchi, Alberto Del Rio, Valentina Grossi, Cristiano Simone. SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer. Cells 2023; 12(20): 2481 doi: 10.3390/cells12202481
|
| 5 |
Rashmi Shah, Deepu Alex, Zhaolin Xu. MET Exon 14 Skipping Alterations in Non-small Cell Lung Carcinoma—Current Understanding and Therapeutic Advances. Oncology & Hematology Review (US) 2021; 16(2): 100 doi: 10.17925/OHR.2021.16.2.100
|
| 6 |
Rachel Sin-Yu Choi, Wing Yin Xenia Lai, Lok Ting Claire Lee, Wing Lam Christa Wong, Xiao Meng Pei, Hin Fung Tsang, Joel Johnson Leung, William Chi Shing Cho, Man Kee Maggie Chu, Elaine Yue Ling Wong, Sze Chuen Cesar Wong. Current and future molecular diagnostics of gastric cancer. Expert Review of Molecular Diagnostics 2019; 19(10): 863 doi: 10.1080/14737159.2019.1660645
|
| 7 |
Yan Wu, Xiaoyuan Yao, Miaolin Zhu, Hai Qian, Lu Jiang, Ting Lan, Min Wu, Ji Pang, Yongchang Chen. PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells. Oncotarget 2016; 7(23): 34190 doi: 10.18632/oncotarget.9074
|
| 8 |
Ilaria Martinelli, Chiara Modica, Cristina Chiriaco, Cristina Basilico, James M. Hughes, Simona Corso, Silvia Giordano, Paolo M. Comoglio, Elisa Vigna. hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02320-6
|
| 9 |
Ranjeet Kumar, Akriti Gupta Jain, Mamoon Ur Rashid, Saeed Ali, Neelam Khetpal, Ishtiaq Hussain, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 1 doi: 10.1007/978-981-13-1486-5_1
|
| 10 |
Chrysovalantou Mihailidou, Michalis V. Karamouzis, Dimitrios Schizas, Athanasios G. Papavassiliou. Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas. Biochimie 2017; 142: 135 doi: 10.1016/j.biochi.2017.09.001
|
| 11 |
Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu. New therapeutic options opened by the molecular classification of gastric cancer. World Journal of Gastroenterology 2018; 24(18): 1942-1961 doi: 10.3748/wjg.v24.i18.1942
|
| 12 |
Jihoon Ko, Jaeyun Jung, Seung Tae Kim, Jung Yong Hong, Sehhoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Soomin Ahn, Kyoung-Mee Kim, Won Ki Kang, Jeeyun Lee. MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610697
|
| 13 |
Sofie Ellebaek Pollmann, Valerie S. Calvert, Shruti Rao, Simina M. Boca, Subha Madhavan, Ivan D. Horak, Andreas Kjaer, Emanuel F. Petricoin, Michael Kragh, Thomas Tuxen Poulsen. Acquired Resistance to a MET Antibody In Vivo Can Be Overcome by the MET Antibody Mixture Sym015. Molecular Cancer Therapeutics 2018; 17(6): 1259 doi: 10.1158/1535-7163.MCT-17-0787
|
| 14 |
Li-Ming Gao, Fang Wang, Yue Zheng, Zhan-Zhao Fu, Lei Zheng, Lan-Lan Chen. Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer. Pathology & Oncology Research 2019; 25(1): 369 doi: 10.1007/s12253-017-0359-3
|
| 15 |
Wei-Zhong Sheng, Yu-Sheng Chen, Chuan-Tao Tu, Juan He, Bo Zhang, Wei-Dong Gao. <i>ANGPTL2</i> expression in gastric cancer tissues and cells and its biological behavior. World Journal of Gastroenterology 2016; 22(47): 10364-10370 doi: 10.3748/wjg.v22.i47.10364
|
| 16 |
Bo Shen, Feixiang Wu, Jiazhou Ye, Rong Liang, Ruping Wang, Ruoying Yu, Xue Wu, Yang W Shao, Jifeng Feng.
Crizotinib-Resistant
MET
Mutations in Gastric Cancer Patients are Sensitive to Type II Tyrosine Kinase Inhibitors
. Future Oncology 2019; 15(22): 2585 doi: 10.2217/fon-2019-0140
|
| 17 |
Jung-Soo Pyo, Guhyun Kang, Hyunjin Cho. Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis. Journal of Gastric Cancer 2016; 16(3): 141 doi: 10.5230/jgc.2016.16.3.141
|
| 18 |
Ferhat Coskun, Semin Ayhan, Ayca Tan, Aydin Isisag. c-MET positivity and its relationship with histopathological findings in gastric carcinomas exhibiting HER2 gene expression. Indian Journal of Pathology and Microbiology 2022; 0(0): 0 doi: 10.4103/ijpm.ijpm_23_21
|
| 19 |
Neelam Khetpal, Saeed Ali, Ranjeet Kumar, Mamoon Ur Rashid, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 29 doi: 10.1007/978-981-13-1486-5_3
|
| 20 |
JM Serpeloni, AFL Specian, DL Ribeiro, LM Benício, HL Nunes, LP Franchi, CQ Rocha, W Vilegas, EA Varanda, IMS Cólus. Fridericia platyphylla (Cham.) L.G. Lohmann root extract exerts cytotoxic and antiproliferative effects on gastric tumor cells and downregulates BCL-XL, BIRC5, and MET genes. Human & Experimental Toxicology 2020; 39(3): 338 doi: 10.1177/0960327119888261
|
| 21 |
Jooseok Kim, Kyung Eui Park, Yoo-Seong Jeong, YeongMun Kim, Hayeon Park, Ji-Hye Nam, Kyungsoo Jung, Woo Sung Son, Hun Soon Jung, Jong-Hwa Lee, Seong Hoon Jeong, Nam Ah Kim, Jae Du Ha, Sung Yun Cho, Yoon-La Choi, Suk-Jae Chung, Jun Young Choi, Sungyoul Hong, Young Kee Shin. Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer. Cancers 2020; 12(6): 1575 doi: 10.3390/cancers12061575
|
| 22 |
Aaron C. Tan, David L. Chan, Wasek Faisal, Nick Pavlakis. New drug developments in metastatic gastric cancer. Therapeutic Advances in Gastroenterology 2018; 11: 175628481880807 doi: 10.1177/1756284818808072
|
| 23 |
Umberto Lucia, Giulia Grisolia. Thermal Resonance and Cell Behavior. Entropy 2020; 22(7): 774 doi: 10.3390/e22070774
|
| 24 |
Mikito Inokuchi, Hideaki Murase, Sho Otsuki, Tatsuyuki Kawano, Kazuyuki Kojima. Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-016-1081-4
|
| 25 |
Bianca Della Croce Vieira Cota, Karine Sampaio Lima, André Márcio Murad, Marcelo Antônio Pascoal Xavier, Mônica Maria Demas Álvares Cabral, Luiz Gonzaga Vaz Coelho. Expression of the c-MET, HGF and VEGF biomarkers in intestinal and diffuse gastric cancer in the Brazilian population: a pilot study for the standardization of the quantitative PCR technique. Applied Cancer Research 2017; 37(1) doi: 10.1186/s41241-017-0029-5
|
| 26 |
Xiaojie Sun, Mengru Zhan, Xun Sun, Wanqi Liu, Xiangwei Meng. C1GALT1 in health and disease (Review). Oncology Letters 2021; 22(2) doi: 10.3892/ol.2021.12850
|
| 27 |
Meritxell Balmaña, Francisca Diniz, Tália Feijão, Cristina C. Barrias, Stefan Mereiter, Celso A. Reis. Analysis of the Effect of Increased α2,3-Sialylation on RTK Activation in MKN45 Gastric Cancer Spheroids Treated with Crizotinib. International Journal of Molecular Sciences 2020; 21(3): 722 doi: 10.3390/ijms21030722
|
| 28 |
Seung Chan Kim, Pulla Reddy Boggu, Ha Na Yu, So Young Ki, Jun Min Jung, Yeon Su Kim, Gi Min Park, Sang Ho Ma, In Su Kim, Young Hoon Jung. Synthesis and biological evaluation of quinoxaline derivatives as specific c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 2020; 30(13): 127189 doi: 10.1016/j.bmcl.2020.127189
|
| 29 |
Emily Harrold, Lynda Corrigan, Simon Barry, Maeve Lowery. Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities. Expert Review of Gastroenterology & Hepatology 2022; 16(7): 601 doi: 10.1080/17474124.2022.2093185
|
| 30 |
Henrique Duarte, Daniela Freitas, Catarina Gomes, Joana Gomes, Ana Magalhães, Celso Reis. Mucin-Type O-Glycosylation in Gastric Carcinogenesis. Biomolecules 2016; 6(3): 33 doi: 10.3390/biom6030033
|
| 31 |
Marina Leite, Miguel S. Marques, Joana Melo, Marta T. Pinto, Bruno Cavadas, Miguel Aroso, Maria Gomez-Lazaro, Raquel Seruca, Ceu Figueiredo. Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions. Cells 2020; 9(2): 513 doi: 10.3390/cells9020513
|
| 32 |
Xin Yang, Hai-Yang Liao, Hai-Hong Zhang. Roles of MET in human cancer. Clinica Chimica Acta 2022; 525: 69 doi: 10.1016/j.cca.2021.12.017
|